You cannot buy a generic Revlimid (lenalidomide) product at this time, as the drug is protected by patents and exclusivity rights that have not yet expired. After the first patent expires in October 2019, companies may decide to make a generic version of this medication. However, new patents, lawsuits, or other circumstances may change the exact date of generic availability.
Can I Buy Generic Revlimid?Revlimid® (lenalidomide) is a prescription medication used to treat certain types of bone marrow diseases, including cancer of the bone marrow. It belongs to a group of medicines known as immunomodulators.
Revlimid is made by Celgene Corporation. It is currently protected from generic competition by patents and exclusivity rights that have yet to expire.
When Will Generic Revlimid Be Available?The first patent for Revlimid is set to expire in October 2019. This is the earliest predictable date that a generic version could become available.
However, other circumstances could come up to delay or shorten the exclusivity period. This could include such things as lawsuits or patents for new Revlimid uses. Once Revlimid goes off-patent, there may be several companies that manufacture a generic Revlimid drug.
Is Lenalidomide a Generic Revlimid?No -- lenalidomide is the active ingredient in Revlimid, but it is not a generic version of it. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version, the original medicine must have gone off-patent, and another company besides the original manufacturer must make the product.